2025 — 1 Books and Research Papers Citing DrugPatentWatch
Ejection Fraction
LL but Poorer - Heart Failure with Reduced Ejection Fraction, an …, 2025 - books.google.com
2024 — 18 Books and Research Papers Citing DrugPatentWatch
Palonosetron versus ondansetron for prophylaxis of postoperative nausea and vomiting in laparoscopic cholecystectomy: a non-inferiority randomized …
FJC Davolos, NS Modolo, LG Braz… - Brazilian Journal of …, 2024 - SciELO Brasil
Evaluation of the Online Pharmaceutical Market and the Dangers of Counterfeit Medicines: Comprehensive Investigation of Illicit Online Trade of semaglutide …
AA Reza - 2024 - pea.lib.pte.hu
Advice to the US FDA to Allow US Pharmacopeia to Create Biological Product Specifications (BPS) to Remove Side-by-Side Analytical Comparisons of …
SK Niazi - Pharmaceutics, 2024 - pmc.ncbi.nlm.nih.gov
A STUDY ON AUTHORIZED GENERICS AND BRANDED GENERICS: A PERSPECTIVE ANALYSIS AMONG THE PHARMACY STUDENTS IN …
A Swain, PC Rout - ANWESHAN, 2024 - anweshan.co.in
Procurement institutions and essential drug supply in low and middle-income countries
NB Zahur, LX Wang - 2024 - econstor.eu
The Science of Supply: Applying Diffusion Models to Predict and Prevent Drug Shortages
AT Eapen - 2024 - search.proquest.com
Global Sustainability and Sustainable Competitive Advantage in Business (Case Study-Teva Pharmaceutical Inc. Strategy Review Between 1976-2020)
FS Olatoye - researchgate.net
Legal Research on Improving the Pharmaceutical Patent Term Extension System for Entering an Aging Society
KY Nam, JI Park - The Journal of Intellectual Property, 2024 - jip.or.kr
Comments Re: Draft Guidance Considering Exercise of March-In Rights-Docket No.: 230831-0207
FD Ledley, E Zhou - 2024 - scholars.bentley.edu
Handbook of Biological Therapeutic Proteins: Regulatory, Manufacturing, Testing, and Patent Issues
S Niazi - 2024 - books.google.com
Considering Returns on Federal Investment in the Negotiated “Maximum Fair Price” of Drugs Under the Inflation Reduction Act: an Analysis
EW Zhou, PG Chaves da Silva, D Quijada… - Institute for New …, 2024 - papers.ssrn.com
SKINNY LABELS: CHANGING SCENARIO OF INDUCED INFRINGEMENT AND PUBLIC POLICY
AD Sandhu - Santa Clara High Technology Law …, 2024 - digitalcommons.law.scu.edu
Biosimilars Development Strategies: Fast to Market Approaches
SK Niazi - 2024 - books.google.com
Драйвер для инноваций
Ю Василишина - Наука и инновации, 2024 - innosfera.belnauka.by
고령화 사회 진입을 향한 제약특허 존속기간 연장제도 개선에 관한 법적 연구
남기연， 박정인 - 지식재산연구, 2024 - dbpia.co.kr
Організація оперативного управління виробництвом на підприємстві-суб'єкті ЗЕД (на прикладі AT «Фармак»)
Д Кірова - 2024 - dspace.znu.edu.ua
Дослідження особливостей зовнішньо-економічної діяльності АТ 'Фарамак'
ІС Мазур - 2024 - evnuir.vnu.edu.ua
Шляхи та методи забезпечення конкурентоспроможності фармацевтичної продукції АТ «Фармак» на зовнішньому ринку
ЄС Іванова - 2023 - dspace.znu.edu.ua
2023 — 19 Books and Research Papers Citing DrugPatentWatch
NIH funding for patents that contribute to market exclusivity of drugs approved 2010–2019 and the public interest protections of Bayh-Dole
FD Ledley, EG Cleary - PLoS One, 2023 - journals.plos.org
Comments Re: Workshop on Transforming Discoveries into Products: Maximizing NIH's Levers to Catalyze Technology Transfer
FD Ledley MD, PD Chaves da Silva - 2023 - scholars.bentley.edu
Response to Department of Commerce, National Institute of Standards and Technology, Agency Information Collection Activities
FD Ledley - 2023 - scholars.bentley.edu
The Relevance of Regional Specificities of Intellectual Property Regulations for Pharmaceutical Industries: Brazilian Law Changes That Immediately Affected Crucial …
TDME de Almeida, T Paes, D Cordeiro… - Medical Research …, 2023 - esmed.org
A Cost-Benefit Analysis of the Medicines Patent Pool
LX Wang - Forthcoming in: Economics Bulletin, Max Planck …, 2023 - papers.ssrn.com
Procurement institutions and essential drug supply in low and middle-income countries
LX Wang, NB Zahur - Procurement Institutions and Essential Drug Supply in …, 2023 - zbw.eu
Mandatory Infringement
C Duan - Fla. L. Rev., 2023 - HeinOnline
Public money, public goods? The Bayh Dole Act and its “manufactured substantially” provision
SJS Smith - 2023 - bora.uib.no
Computer-aided drug design-based system pharmacology applications for the treatment of diabetes mellitus
S Bibi, MM Hasan, MS Hossain, MS Khan… - … Approaches in Drug …, 2023 - Elsevier
The Economic Burden of Heart Failure with Reduced Ejection Fraction: Living Longer but Poorer?
LA Allen, EF Lowe, DD Matlock - Cardiology Clinics, 2023 - cardiology.theclinics.com
Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalers
E de Pablo, P O'Connell, R Fernández-García… - International Journal of …, 2023 - Elsevier
Do financial literacy and entrepreneurial skills lead to improved performance? Evidence from Swiss Biotechnology sector.
C Santos, H Freire - Journal of Commercial Biotechnology, 2023 - search.ebscohost.com
Nano therapy Spotlight: Arestin™ Minocycline Microspheres. Chem Pharm Res. 2023; 5 (1): 1-8
D Plemmons, KB Sneed, Y Pathak - Correspondence: Yashwant Pathak … - scivisionpub.com
Recent advances in industrial applications of seaweeds
S Polat, M Trif, A Rusu, V Šimat, M Čagalj… - Critical reviews in …, 2023 - Taylor & Francis
The Importance of Considering Price Metrics and Market Dynamics in US Economic Evaluations: The Case of SGLT-2 Inhibitors in the Treatment of Type 2 …
M Willis, C Neslusan, A Nilsson - ispor.org
Linking access to finance and governance structure with financial performance of biotechnology firms: the mediation of financial literacy.
L Gabriele, V David - Journal of Commercial Biotechnology, 2023 - search.ebscohost.com
Heart failure with reduced ejection fraction, An Issue of Cardiology Clinics, E-Book: Heart failure with reduced ejection fraction, An Issue of Cardiology Clinics …
A Ghafoor - 2023 - books.google.com
Emerging role of Machine Learning in field of Pharmacology
P Rajput, A Pramanik, N Yamsani - … Conference on Advanced …, 2023 - ieeexplore.ieee.org
Шляхи та методи забезпечення конкурентоспроможності фармацевтичної продукції АТ «Фармак» на зовнішньому ринку
ЄС Іванова - 2023 - dspace.znu.edu.ua
2022 — 22 Books and Research Papers Citing DrugPatentWatch
Six drugs facing key patent expirations and potential generic entry from May to June 2022
Y Friedman - Pharmaceutical Patent Analyst, 2022 - Future Science
Global drug diffusion and innovation with the medicines patent pool
LX Wang - Journal of Health Economics, 2022 - Elsevier
AI (Re) Defining Pharmaceutical ExclusivitiesJ Kimball, S Ragavan - Biotechnology Law Report, 2022 - liebertpub.com
https://www.liebertpub.com/doi/abs/10.1089/blr.2021.29257.sr
Essential Medicines and Patent on the World Health Organization Essential Medicines List 22nd Edition (2022)
M Schultz - Geneva Network, May, 2022 - geneva-network.com
Vasopressin: The Impact of Predatory Patents on a Captive ICU Marketplace
LKN Peterson, JW Devlin - Critical Care Medicine, 2022 - journals.lww.com
Noticing Patents
JR Thomas - Colum. Sci. & Tech. L. Rev., 2022 - HeinOnline
Pharma Patent Valuation
R Moro-Visconti - … Corporate Valuation: From Digital Networking to ESG …, 2022 - Springer
Overlap of Trademarks with Other Intellectual Property Rights: The Strategies of Global Brands
MD Selvakumar - Beijing L. Rev., 2022 - HeinOnline
Patent Linkages and Its Impact on Access to Medicines: Challenges, Opportunities for Developing Countries
KD Raju - Access to Medicines and Vaccines: Implementing …, 2022 - library.oapen.org
Direct-to-consumer teledermatology growth: a review and outlook for the future
V Ranpariya, D Kats, JB Lipoff - Cutis, 2022 - cdn.mdedge.com
Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and …
FW Thielen, RJSD Heine, S van den Berg… - Cytotherapy, 2022 - Elsevier
The coming of age of biosimilars: a personal perspective
SK Niazi - Biologics, 2022 - mdpi.com
How Compounding Pharmacies Fill Critical Gaps in Pediatric Drug Development Processes: Suggested Regulatory Changes to Meet Future Challenges
RB MacArthur, LD Ashworth, K Zhan, RH Parrish - Children, 2022 - mdpi.com
A REVIEW: 3D PRINTING IN PHARMA SECTOR
S Mishra, R Kumar - 2022 - wjpr.s3.ap-south-1.amazonaws.com
Chronopharmacology of immune-related diseases
S Ohdo, S Koyanagi, N Matsunaga - Allergology International, 2022 - jstage.jst.go.jp
SACUBITRIL/VALSARTAN (ENTRESTO): A REVIEW ON DEVELOPMENT OF ANALYTICAL METHODS AND ITS ASSESSMENT IN PURE, BULK …
CK SINGH - 2022 - academia.edu
Medtech and Biotech Valuation
R Moro-Visconti - … Corporate Valuation: From Digital Networking to ESG …, 2022 - Springer
Patent Philanthropy
H Sun - Cornell Int'l LJ, 2022 - HeinOnline
Astrazeneca equity research-adapting to a dynamic pharmaceutical sector as a key to success
A Papp - 2022 - run.unl.pt
Astrazeneca equity research-big pharma on the brink of future changes in oncology
JK Kerkow - 2022 - run.unl.pt
РНТБ–45 лет на службе науке и производству. Информационно-ресурсное обеспечение научно-исследовательской деятельности
НС Шалыгина - Научные и технические библиотеки, 2022 - ntb.gpntb.ru
Implementación del “linkage farmacéutico” en Chile.¿ A qué nos obliga el Tratado Integral y Progresista de Asociación Transpacífico?
PA Viollier Bonvin, S Valenzuela Pulgar - Revista de derecho …, 2022 - SciELO Chile
2021 — 20 Books and Research Papers Citing DrugPatentWatch
Better than a compromise, a third way: Using patent pooling to accelerate access to vaccines and treatments against Covid-19
E Billette de Villemeur, V Dequiedt… - Available at SSRN …, 2021 - papers.ssrn.com
Medicines Patent Pool and HIV Drug Cocktail Diffusion and Innovation
LX Wang - Academy of Management Proceedings, 2021 - journals.aom.org
Global Drug Diffusion and Innovation with the Medicines Patent Pool
LX Wang - Available at SSRN 3426554, 2021 - papers.ssrn.com
Is Drug Patent Protection a Determinant of the Location of Pharmaceutical FDI? China's Experience
N Yacoub, H Souei - Innovation, Catch-up and Sustainable Development …, 2021 - Springer
Pharmaceutical opioid marketing and physician prescribing behavior
S Beilfuss, S Linde - Health Economics, 2021 - Wiley Online Library
Affordable Medicines and Innovation: Consequences and Lessons from Countries with Different Patentability Standards
P Vimalnath, O Gurgula, N Scott-Ram… - Bio-Science Law …, 2021 - papers.ssrn.com
A Prescription for America's Prescriptions
H Gintis - Emory Int'l L. Rev., 2021 - HeinOnline
Do current radical innovation measures actually measure radical drug innovation?
I Stiller, A van Witteloostuijn, B Cambré - Scientometrics, 2021 - Springer
Response to proposed rulemaking on Bayh Dole
FD Ledley - 2021 - scholars.bentley.edu
MEDTECH AND BIOTECH VALUATION
RM Visconti - 2021 - researchgate.net
Access to medicinal products
T DE JONGH, L VELTEN, L SCHRIJVER - 2021 - technopolis-group.com
Abuse-deterrent opioid formulations and the opioid crisis: a pharmacist's perspective
S Gadd, N Cox, J Samuelson, A Kenney… - Therapeutic Drug …, 2021 - journals.lww.com
Beefing up Skinny Labels: Induced Infringement as a Question of Law
GT Potter - Notre Dame L. Rev., 2021 - HeinOnline
Post COVID-19 Supply Chain Optimization for the Indian Pharmaceutical Industry using AI Techniques
P Shah - Intersect: The Stanford Journal of Science, Technology …, 2021 - ojs.stanford.edu
Palonosetron versus ondansetron for prophylaxis of postoperative nausea and vomiting in laparoscopic cholecystectomy: a non-inferiority randomized …
FJC Davolos, NS Modolo, LG Braz… - Brazilian Journal of …, 2021 - Elsevier
Simultaneous automated image analysis and Raman spectroscopy of powders at an individual particle level
A Sekulovic, R Verrijk, T Rades, A Grabarek… - … of Pharmaceutical and …, 2021 - Elsevier
The valuation of pharma patents
R Moro Visconti - Available at SSRN, 2021 - papers.ssrn.com
Centrifuged-concentrated intravitreal slurry triamcinolone acetonide: An inexpensive, easy, and viable alternative to long-term steroid delivery
SM Malinowski, JA Wasserman - Journal of VitreoRetinal …, 2021 - journals.sagepub.com
The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myeloma
JP MacEwan, I Majer, JW Chou… - Therapeutic Advances …, 2021 - journals.sagepub.com
Mieux qu'un compromis, une troisième voie: le panier de brevets pour accélérer l'accès aux vaccins et traitements contre la COVID-19
EB de Villemeur, V Dequiedt, B Versaevel - Revue d'économie du …, 2021 - cairn.info
2020 — 36 Books and Research Papers Citing DrugPatentWatch
Two drugs facing key patent expirations and potential generic entry from November 2020 to December 2020
Y Friedman - Pharmaceutical Patent Analyst, 2020 - search.proquest.com
Three drugs facing key patent expirations and potential generic entry from June 2020 to July 2020
Y Friedman - Pharmaceutical Patent Analyst, 2020 - search.proquest.com
Three drugs facing key patent expirations and potential generic entry from September to October 2020
Y Friedman - Pharmaceutical Patent Analyst, 2020 - search.proquest.com
Identification of US-pharmaceutical patents expiring between 2018 and 2022 and their effect on the Brazilian domestic market
TDM Paes, LF Aguiar, TD Martins - World Patent Information, 2020 - Elsevier
Essential Medicines and Patents: Recent Trends in the Latest Editions of the World Health Organization's Essential Medicines List
M Schultz, J McDole - geneva-network.com
Two drugs facing key patent expirations and potential generic entry from July to August 2020
Y Friedman - Pharmaceutical Patent Analyst, 2020 - Future Science
Government as the first investor in biopharmaceutical innovation: Evidence from new drug approvals 2010–2019
E Cleary, MJ Jackson, F Ledley - Institute for New Economic …, 2020 - papers.ssrn.com
Five drugs facing key patent expirations and potential generic entry from April to May 2020
Y Friedman - Pharmaceutical Patent Analyst, 2020 - Future Science
Weak links: Instabilities and areas for improvement in the drug supply chain
LM Anson, K Taylor - Journal of the American Pharmacists Association, 2020 - Elsevier
Access to essential medicines to guarantee women's rights to health: The pharmaceutical patents connection
JHM Mike - The Journal of World Intellectual Property, 2020 - Wiley Online Library
Societal and economic impact of Accelerator Mass spectrometry
S van der Schans - 2020 - repository.tudelft.nl
Perspective, perceptions, and promulgation of biosimilars: A questionnaire-based study to assess and understand the current challenges of biosimilars to the …
KK Bhardwaj, K Bangarurajan, T Naved… - Journal of Pharmacy & …, 2020 - ncbi.nlm.nih.gov
Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation
AV Nikitina, FV Gorkavenko… - …, 2020 - pharmacoeconomics.ru
The effectiveness of the Swiss and Canadian antibiotic distribution system compared
S Janett - 2020 - sonar.ch
Identifying and Averting the Difficulties in Converting Biotechnological Innovations into Successful Commerce: Case of Bahrain.
AI Al-Alawi, YF El-Tony, EI AlAlawi… - Arab Gulf Journal of …, 2020 - researchgate.net
Potential Impact of Provisions of Intellectual Property Rights Related to the Pharmaceutical Sector in the Comprehensive and Progressive Agreement for Trans-Pacific …
TM Le - MIPLC Master Thesis Series (2019/20), 2020 - papers.ssrn.com
Caps on Capsules: Prescription for Lower Drug Prices in the United States
C Chasse - Food & Drug LJ, 2020 - HeinOnline
Process Intensification for Pharmaceutical Granules Preparation Using Spherical Agglomeration
CW Chen - 2020 - ir.lib.ncu.edu.tw
Biosimilar's Growth in Pharmerging Markets: An Analysis of the Regulatory Environments
R Batel - 2020 - University of the Western Cape
Sentiments Analysis of the Medical or Pharmacy Shops Business to Develop in Terms of Communication, Productivity & Efficiency in Their Retails Business
RD Jadhav, DMS Kadam - Journal of University of Shanghai for Science and … - jusst.org
Protecting and Securing Data Through Blockchain Across Industries
S Kendzierskyj, H Jahankhani - CYBER SECURITY …, 2020 - World Scientific
Physician and Hospital Utilization of P2Y12 Inhibitors in ST-Segment–Elevation Myocardial Infarction in the United States: A Study From the National Cardiovascular …
KF Faridi, KN Garratt, KF Kennedy… - … Quality and Outcomes, 2020 - Am Heart Assoc
ADAM HALL, ALEX ESPOSITO, BRAD HORNSBY, COLSON MYERS
J PARK, K WELLS, M MEDINA, W LEWIS
Pulling the Wrong Lever Opens a Trap Door: Using Taxes to Fight the Opioid War
MM Kwon - 2020 - ir.law.utk.edu
Millennials vs. Cyborgs and Blockchain Role in Trust and Privacy
H Jahankhani, S Kendzierskyj… - Handbook of Research on …, 2020 - igi-global.com
Analytical methods in the clinical phase of development
JD Orr, GL Reid - Specification of Drug Substances and Products, 2020 - Elsevier
Pharmacogenetics in clopidogrel
S Osama - 2020 - um.edu.mt
Government as the First Investor in Biopharmaceutical Innovation: Evidence From New Drug Approvals 2010–2019 Ekaterina Galkina Cleary, Matthew J …
FD Ledley - 2020 - researchgate.net
Sitagliptin (Januvia) patent litigation: Another link in the judicial train of 'Proactive Infringement'of patented rights in developing countries
Z Iqbal, S Sadaf - Journal of Generic Medicines, 2020 - journals.sagepub.com
UPLC-MS/MS Determination of GLP-1 Analogue, Liraglutide A Bioactive Peptide in Human Plasma
T Gorella, PMN Rajesh, P Wagh - waters.com
Формула практической полезности и эффективности патентного поиска
Н Сафронова - Наука и инновации, 2020 - cyberleninka.ru
Palonosetrona versus ondansetrona para profilaxia de náuseas e vômitos pós-operatórios em colecistectomias videolaparoscópicas. Estudo controlado randomizado …
FJC Davolos - 2020 - repositorio.unesp.br
企業合併與收購之效益分析
林秀琦 - 2020 - airitilibrary.com
Los derechos de propiedad intelectual y el acceso a los medicamentos para enfrentar a la COVID-19
FA Gómez - 2020 - academia.edu
Intersección entre competencia y patentes: Hacia un ejercicio pro-competitivo de los derechos de patente en el sector farmacéutico
MJ Rodríguez Gómez - 2020 - econstor.eu
COVID-19 Tedavisinde Kullanılan İlaçların Biyofarmasötik, Farmakokinetik ve Patent Değerlendirmeleri: Ülkemizde Eşdeğer İlaçların Geliştirilmesindeki Güncel …
DY Usta, ZŞ Teksin - Gazi Medical Journal, 2020 - researchgate.net
2019 — 11 Books and Research Papers Citing DrugPatentWatch
Are Medicine Prices High and Unaffordable after Trips? Evidence from Pharmaceutical Industry in India
S Chaudhuri - Evidence from Pharmaceutical Industry in India …, 2019 - papers.ssrn.com
Healthcare Patient and Clinical Research
S Kendzierskyj, H Jahankhani - … and Clinical Trial: Securing Patient Data, 2019 - Springer
Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk: A Cost Consequence Simulation from PARIS
U Baber, DE Leisman, DJ Cohen… - … Quality and Outcomes, 2019 - Am Heart Assoc
Characterization and solution structure of multi-domain proteins and protein complexes
AV Kulakova - 2019 - orbit.dtu.dk
Economic evaluation of the use of non-vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare …
N Bennaghmouch, AJWM de Veer… - … Journal-Quality of …, 2019 - academic.oup.com
Property in human genetic material: An old legal question for a new technological age
J Pila - The Oxford Handbook of Comparative Health Law …, 2019 - papers.ssrn.com
An evaluation of sodium oxybate as a treatment option for narcolepsy
VC Abad - Expert Opinion on Pharmacotherapy, 2019 - Taylor & Francis
Patent abandonment and subsequent cumulative inventions
W Zheng - 2019 - core.ac.uk
The effect of patent expiration on sales of branded competitor drugs in a therapeutic class
J Fujimoto, DM Tien, S Snyder… - Journal of Generic …, 2019 - journals.sagepub.com
Основа научных исследований-информационная база
Н Сафронова, Т Нечаева, О Сонных - Наука и инновации, 2019 - cyberleninka.ru
Оптимизация лекарственного обеспечения пациентов со злокачественными новообразованиями на уровне субъекта Российской Федерации
АВ Никитина, ФВ Горкавенко… - Фармакоэкономика …, 2019 - cyberleninka.ru
2018 — 9 Books and Research Papers Citing DrugPatentWatch
More Than One Decade Of Viagra: What Lessons Can Be Learned From Intellectual Property Rights In The Erectile Dysfunction Market?
CRP Da Veiga, CP Da Veiga, JM Del Corso… - … Property to Promote …, 2018 - World Scientific
Ships in the Night: Resolving Administrative Conflict Between FDA-and Patent-Related Legislation
CA Garcia, J Stroud - Am. UL Rev., 2018 - HeinOnline
From American Acts to CPTPP Rules: the enlightenment to patent linkage reforms in China
S Diao - … on Judicial, Administrative and Humanitarian Problems …, 2018 - atlantis-press.com
Discovery and development of varenicline for smoking cessation
CJ Jordan, ZX Xi - Expert opinion on drug discovery, 2018 - Taylor & Francis
Precision medicine as a promising tool to empower research in healthcare industry
S Mayank, S Suhani - GSC Biological and Pharmaceutical …, 2018 - gsconlinepress.com
Study on the economic impact of supplementary protection certificates, pharmaceutical incentives and rewards in Europe
C Economics - 2018 - health.ec.europa.eu
The Commercilazation of a Noval Antithrombotic Drug
Y Dai - 2018 - Case Western Reserve University
Fuentes de información de patentes y procedimiento para las búsquedas de libertad de acción en Cuba
RG Hernández, MC Gibert - … de Información en Ciencias de la …, 2018 - medigraphic.com
Государственные гарантии доступности лекарственных средств в России и за рубежом
ФВ Цомартова - Журнал зарубежного законодательства и …, 2018 - cyberleninka.ru
2017 — 9 Books and Research Papers Citing DrugPatentWatch
Orphan Drug legislation: evaluation of the impact of market exclusivity extension
P Gorry - 2017 - ideas.repec.org
Measuring exaptation and its impact on innovation, search, and problem solving
P Andriani, A Ali, M Mastrogiorgio - Organization Science, 2017 - pubsonline.informs.org
Where Are Drugs Invented, and Why Does It Matter?
Y Friedman - ACS Medicinal Chemistry Letters, 2017 - ACS Publications
Repurposing for Alzheimer's and Parkinson's Diseases
H Mucke - Drug repositioning: approaches and applications for …, 2017 - books.google.com
Current trend in drug delivery considerations for subcutaneous insulin depots to treat diabetes
PV Jayakrishnapillai, SV Nair… - Colloids and Surfaces B …, 2017 - Elsevier
Diazepam in the treatment of moderate to severe alcohol withdrawal
SJ Weintraub - CNS drugs, 2017 - Springer
The efficacy and safety of 12 weeks of sofosbuvir and ledipasvir versus sofosbuvir, ledipasvir, and ribavirin in patients with chronic hepatitis C, genotype 1 …
W Stokes, C Fenton, F Clement, M James… - Canadian Journal of …, 2017 - hindawi.com
4 Systematic Drug
SN Deftereos, A Persidis, A Persidis… - … and Applications for …, 2017 - books.google.com
A indústria farmacêutica brasileira ea oferta de medicamentos para o tratamento da insuficiência cardíaca no SUS
JM Araújo - 2017 - repositorio.ufba.br
2016 — 5 Books and Research Papers Citing DrugPatentWatch
Moving from preclinical research to development
V Pestonjamasp - Journal of Commercial Biotechnology, 2016 - thinkbiotech.com
Propensity score-based approaches to confounding by indication in individual patient data meta-analysis: non-standardized treatment for multidrug resistant …
GJ Fox, A Benedetti, CD Mitnick, M Pai, D Menzies… - PloS one, 2016 - journals.plos.org
Online Appendix for'Delayed Entry Settlements at the Patent Office'
E Hovenkamp, J Lemus - International Review of Law and Economics …, 2016
La twittliste du secteur pharmaceutique
F Deprez - Netsources, 2016 - search.proquest.com
Plataformas on-line de vigilancia/inteligencia: caracterización e implementación práctica
Y Benítez Nieto - 2016 - upcommons.upc.edu
2015 — 4 Books and Research Papers Citing DrugPatentWatch
Valuation of Novo Nordisk A/S 5th February 2015
JB Barslund - 2015 - research.cbs.dk
Impact of marketing investments on firm value
M Chaudhuri - 2015 - search.proquest.com
Oral anti-diabetic agents-review and updates
PO Osadebe, EU Odoh, PF Uzor - British Journal of Medicine and Medical Research, 2015
Verdivurdering av firmaet Photocure ASA
TH Larsen - 2015 - nordopen.nord.no
2014 — 10 Books and Research Papers Citing DrugPatentWatch
More Than One Decade Of Viagra: What Lessons Can Be Learned From Intellectual Property Rights In The Erectile Dysfunction Market?
CR Pereira Da Veiga… - … Journal of Innovation …, 2014 - World Scientific
The lag time in initiating clinical testing of new drugs in combination with radiation therapy, a significant barrier to progress?
P Blumenfeld, RM Pfeffer, Z Symon, RB Den… - British journal of …, 2014 - nature.com
Alberto Galasso
M Schankerman - 2014 - hoover.org
Vorapaxar, a Protease-Activated Receptor-1 Antagonist, a Double–Edged Sword!
B Bhandari, B Mehta - Recent Patents on Cardiovascular Drug …, 2014 - ingentaconnect.com
Essays on the Competitive Dynamics of Innovation and Product Quality
MS Mills - 2014 - search.proquest.com
Preparation, characterization and biological evaluation of chitosanmoxifloxacin prodrugs for pharmaceuticals
A Semwal, S Ramandeep - Marmara Pharmaceutical Journal, 2014 - dergipark.org.tr
The nature of Asian biopharmaceutical innovation
Y Friedman - Nature biotechnology, 2014 - nature.com
Multidimensional LC-MS/MS enables simultaneous quantification of intact human insulin and five recombinant analogs in human plasma
EE Chambers, KJ Fountain, N Smith, L Ashraf… - Analytical …, 2014 - ACS Publications
进口药比国产药贵多少?
黄楚珺 - 消费者报道, 2014 - cqvip.com
Terapia sekwencyjna w ostrym bólu pooperacyjnym, z zastosowaniem oksykodonu z naloksonem, w kontekście badań klinicznych.
A Rupniewska-Ładyko… - … & Rescue Medicine …, 2014 - akademiamedycyny.pl
2013 — 9 Books and Research Papers Citing DrugPatentWatch
Transdermal delivery: product and patent update
H Gupta, RJ Babu - Recent patents on drug delivery & …, 2013 - ingentaconnect.com
The structure and business of biopharmaceutical companies including the management of risks and resources
J Samanen - Introduction to Biological and Small Molecule Drug …, 2013 - Elsevier
Amphotericin B formulations–the possibility of generic competition
DR Serrano, MP Ballesteros… - Pharmaceutical …, 2013 - ingentaconnect.com
Katelyn Sylvester, Megan Rocchio, Nahal Beik & John Fanikos
CEHM Rep - researchgate.net
Biosimilars: an emerging category of biologic drugs for emergency medicine practitioners
K Sylvester, M Rocchio, N Beik, J Fanikos - Current Emergency and …, 2013 - Springer
Repurposed drugs in metabolic disorders
J Finsterer, M Frank - Current Topics in Medicinal Chemistry, 2013 - ingentaconnect.com
RP-HPLC method for the estimation of tamsulosin and solifenacin in bulk and its dosage forms
DS Israel, K Krishnachaitanya… - International Journal of …, 2013 - Citeseer
Formulation and Technology Transfer Studies on Antifungal Injection
D Das - 2013 - search.proquest.com
Análise enantiosseletiva da fluvastatina em plasma por eletroforese capilar
JMC Yokoya - 2013 - teses.usp.br
2012 — 2 Books and Research Papers Citing DrugPatentWatch
Patent protection policy of the therapeutic groups аngiotensin II receptor antagonists
M Manova, A Stoimenova, L Peikova, P Peikov… - 2012 - … медицинска библиотека, МУ …
Economic analysis of the cost savings after implementation of antibiotic policy in hospital
M Manova, A Savova, A Stoimenova… - 2011 - … медицинска библиотека, МУ …
2011 — 1 Books and Research Papers Citing DrugPatentWatch
Influência da porosidade total do leito na cromatografia preparativa em batelada dos enantiômeros do omeprazol.
AFN DOMINGUES, CC SANTANA - 2012 - alice.cnptia.embrapa.br
2010 — 9 Books and Research Papers Citing DrugPatentWatch
Proactive Planning of the Timing of a Partial Switch of a Prescription to Over‐the‐Counter Drug
GE Fruchter, MK Mantrala - Production and Operations …, 2010 - Wiley Online Library
Patinformatics–an emerging scientific discipline
MK Raturi, PK Sahoo, S Mukherjee… - Available at SSRN …, 2010 - papers.ssrn.com
Patinformatics: An Emerging Scientific Discipline
AK Tiwari, MK Raturi, S Mukherjee, PK Sahoo - SSRN, March, 2010 - academia.edu
Essay on intellectual property and patent backed financing
C Odasso - 2010 - aisberg.unibg.it
Location of pharmaceutical innovation: 2000-2009
Y Friedman - Nature reviews. Drug discovery, 2010 - nature.com
Oral Controlled Release‐Based Products for Life Cycle Management
N Davar, S Ghosh - … Design and Drug Delivery: Theory to …, 2010 - Wiley Online Library
Reporting and Interpretation of the CYP2C19 Genotyping Test for Clopidogrel Dosing
SD Brouse, JC Fullerton… - Current …, 2010 - ingentaconnect.com
Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate-and low-cardiovascular-risk individuals for statin therapy
KK Lee, LE Cipriano, DK Owens, AS Go, MA Hlatky - Circulation, 2010 - Am Heart Assoc
Patent analysis: a tool for making strategic business decisions
E Norman - 2010 - biotechblog.com
2009 — 2 Books and Research Papers Citing DrugPatentWatch
Dosed without Prescription: Preventing Pharmaceutical
M Wu, D Atchley, L Greer, S Janssen… - … Defense Council (NRDC …, 2009 - nrdc.org
AS. Market Analysis of Currently Available Prescription Drugs
J Zhang, SU Ahmed - 2009 - Association for Business and …
2008 — 5 Books and Research Papers Citing DrugPatentWatch
A United States Market Entry Analysis for a New Medical Device
P Doerfling, S Inouye, L Poznanski - 2008 - summit.sfu.ca
Focus on lowest net cost drug reduces costs for patients, plan sponsors
DH Felthouse - American Health & Drug Benefits, 2008 - ncbi.nlm.nih.gov
Intellectual property portfolio securitization: an evidence based analysis
M Calderini, MC Odasso - Innovation Studies Working Paper …, 2008 - papers.ssrn.com
ASHP guidelines on medication cost management strategies for hospitals and health systems
JM Hoffman, LJ Koesterer… - Am J Health Syst …, 2008 - academic.oup.com
2007 — 2 Books and Research Papers Citing DrugPatentWatch
Assessing decision inputs in drug development between small, early stage companies and big pharma: is there is a difference?
DS Rippy - 2007 - dspace.mit.edu
Nano-based drugs and medical devices: FDA's track record
CH Strickland - Nanotech. L. & Bus., 2007 - HeinOnline
